- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Australian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
59
59 companies
Firebrick Pharma
Market Cap: AU$19.1m
Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.
FRE
AU$0.091
7D
-3.2%
1Y
75.0%
Alterity Therapeutics
Market Cap: AU$49.4m
Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.
ATH
AU$0.009
7D
-10.0%
1Y
100.0%
Little Green Pharma
Market Cap: AU$40.9m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.14
7D
3.8%
1Y
3.8%
Clinuvel Pharmaceuticals
Market Cap: AU$584.4m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$11.70
7D
0.8%
1Y
-14.9%
Vita Life Sciences
Market Cap: AU$108.5m
A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.
VLS
AU$1.95
7D
1.6%
1Y
-18.8%
Immutep
Market Cap: AU$422.1m
A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.29
7D
-1.7%
1Y
-24.7%
Invion
Market Cap: AU$8.9m
A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.
IVX
AU$0.12
7D
-8.0%
1Y
-77.0%
LTR Pharma
Market Cap: AU$86.9m
A biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.
LTP
AU$0.48
7D
-20.0%
1Y
57.4%
Algorae Pharmaceuticals
Market Cap: AU$8.4m
A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.
1AI
AU$0.005
7D
-16.7%
1Y
-44.4%
Argenica Therapeutics
Market Cap: AU$102.5m
A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.
AGN
AU$0.80
7D
3.2%
1Y
33.3%
Neuren Pharmaceuticals
Market Cap: AU$1.6b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$12.62
7D
2.6%
1Y
-37.6%
Nyrada
Market Cap: AU$21.0m
A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.
NYR
AU$0.10
7D
0%
1Y
4.2%
Arovella Therapeutics
Market Cap: AU$89.4m
A biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally.
ALA
AU$0.084
7D
-16.0%
1Y
-35.4%
Radiopharm Theranostics
Market Cap: AU$65.4m
Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.
RAD
AU$0.028
7D
-12.5%
1Y
-50.9%
Clarity Pharmaceuticals
Market Cap: AU$784.1m
A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.
CU6
AU$2.44
7D
-13.2%
1Y
-14.4%
Biotron
Market Cap: AU$2.7m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.003
7D
0%
1Y
-96.1%
Actinogen Medical
Market Cap: AU$106.5m
A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.
ACW
AU$0.034
7D
0%
1Y
19.3%
Invex Therapeutics
Market Cap: AU$5.4m
A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.
IXC
AU$0.072
7D
2.9%
1Y
-15.3%
Race Oncology
Market Cap: AU$191.1m
A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.
RAC
AU$1.10
7D
-8.3%
1Y
-19.7%
EZZ Life Science Holdings
Market Cap: AU$73.8m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.57
7D
3.6%
1Y
203.9%
Percheron Therapeutics
Market Cap: AU$12.0m
Engages in the research and development of novel antisense pharmaceuticals in Australia.
PER
AU$0.011
7D
10.0%
1Y
-87.4%
PYC Therapeutics
Market Cap: AU$629.9m
A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.
PYC
AU$1.35
7D
16.9%
1Y
66.7%
Orthocell
Market Cap: AU$359.9m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.
OCC
AU$1.50
7D
3.8%
1Y
294.7%
Immuron
Market Cap: AU$16.3m
A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.
IMC
AU$0.07
7D
-1.4%
1Y
-33.3%
Amplia Therapeutics
Market Cap: AU$27.2m
A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.
ATX
AU$0.07
7D
-5.4%
1Y
-6.7%
Island Pharmaceuticals
Market Cap: AU$33.7m
A drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America.
ILA
AU$0.17
7D
2.9%
1Y
191.7%
NeuroScientific Biopharmaceuticals
Market Cap: AU$5.5m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.038
7D
-7.3%
1Y
-20.8%
Tissue Repair
Market Cap: AU$16.0m
A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.
TRP
AU$0.27
7D
1.9%
1Y
20.5%
Vitrafy Life Sciences
Market Cap: AU$83.6m
Provides cryopreservation solutions in Australia.
VFY
AU$1.31
7D
-3.7%
1Y
n/a
Tryptamine Therapeutics
Market Cap: AU$46.0m
A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.
TYP
AU$0.036
7D
-5.3%
1Y
n/a
Starpharma Holdings
Market Cap: AU$40.0m
A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.
SPL
AU$0.097
7D
0%
1Y
-25.4%
Chimeric Therapeutics
Market Cap: AU$7.9m
A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.
CHM
AU$0.005
7D
-16.7%
1Y
-83.3%
Noxopharm
Market Cap: AU$25.4m
A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.
NOX
AU$0.087
7D
19.2%
1Y
42.6%
Cryosite
Market Cap: AU$38.1m
Provides outsourced clinical trials logistic services in Australia.
CTE
AU$0.78
7D
1.3%
1Y
14.7%
Medical Developments International
Market Cap: AU$62.5m
Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.56
7D
-11.2%
1Y
-8.3%
Imugene
Market Cap: AU$253.8m
A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.
IMU
AU$0.034
7D
-2.9%
1Y
-67.6%